Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02178787 · ClinicalTrials.gov registry record

UTLight-transcranial Doppler Assessment of Regional Cerebral Autoregulation

A clinical trial, sponsored by Beth Israel Deaconess Medical Center.

Completed
Registry status
60
Enrollment target

NCT02178787: Completed study, sponsored by Beth Israel Deaconess Medical Center.

NCT02178787 is a clinical trial that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02178787 has completed, sponsored by Beth Israel Deaconess Medical Center.

COMPLETED
Registry status
60 participants
Enrollment target

Study Summary

Cerebral autoregulation (CA) is a complex mechanism that serves the essential and vital purpose of controlling cerebral blood flow and metabolism. A stable and optimal brain blood flow is imperative for normal brain function. Diabetes Mellitus (DM ) is associated with microvascular disease that alters CA and also with autonomic failure that may lead to orthostatic hypotension (OH). These conditions may lead to decreased brain blood flow in upright position. This observational study will compare two technologies that evaluate brain blood flow during standing up and other maneuvers in people with and without type 2 diabetes. These technologies are transcranial Doppler and UTLight technology (CerOx). This study will determine the safety and feasibility of CerOx technology for continuous monitoring of cerebral blood flow.

Primary Outcome

CO2 reactivity will be measured as the slope of regression between TCD\_BFV and CO2 changes during baseline, hyperventilation, and CO2 re-breathing.

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2014-04
Est. Completion 2015-06

What the finished NCT02178787 record still lists

NCT02178787 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT02178787 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02178787 about?

NCT02178787 is a clinical study titled "UTLight-transcranial Doppler Assessment of Regional Cerebral Autoregulation". Cerebral autoregulation (CA) is a complex mechanism that serves the essential and vital purpose of controlling cerebral blood flow and metabolism. A stable and optimal brain blood flow is imperative for normal brain function. Diabetes Mellitus (DM ) is associated with microvascular disease that alte...

What is the current status of trial NCT02178787?

This trial is currently completed. The enrollment target is 60 participants. The study started on 2014-04. Estimated completion is 2015-06.

Who is sponsoring clinical trial NCT02178787?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02178787, the US trial registry maintained by the National Library of Medicine. NCT02178787 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.